The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
基本信息
- 批准号:9318540
- 负责人:
- 金额:$ 31.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-05 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdenocarcinomaAffinityAnteriorAntibioticsAntralBacteriaBindingBiochemicalBiological AssayBiophysicsCellsChemicalsChemoreceptorsChemotaxisConfocal MicroscopyCuesDataDiseaseDisease OutcomeDrug or chemical Tissue DistributionDuodenal UlcerEngineeringEnvironmentEpithelialEpithelial CellsEpitheliumGastric GlandsGastric Parietal CellsGastritisHabitatsHelicobacter InfectionsHelicobacter pyloriHumanImpairmentIndividualInfectionKnowledgeLigandsMalignant NeoplasmsMeasuresMediatingMedicalMethodsMicrobial BiofilmsMovementMucous MembraneMusOrganPathogenesisPatternPerceptionPeriplasmic Binding ProteinsPopulationPropertyResearch PersonnelResolutionRoleSignal TransductionStomachStomach DiseasesStructural ProteinStructureSurfaceSystemTestingTropismUlcerUreaVAI-2basecell motilitydensitydesignin vivo Modelinsightmonolayermutantnext generationnovelpathogenperiplasmpreventpublic health relevancequorum sensingreceptorresponsestructural biology
项目摘要
DESCRIPTION (provided by applicant): Helicobacter pylori is a human gastric pathogen that colonizes half the world's population and causes a wide range of diseases including gastritis, ulcers, and cancer. The distribution of the bacteria in the stomach is correlated with disease outcomes, but the factors that determine this distribution are unknown. We hypothesize that chemotaxis, the ability of bacteria to sense and orient their movement in response to chemical gradients in their environment is a key determinant of H. pylori distribution in the stomach. H. pylori is ideally suited for testing the role of bacterial chemotaxis in tissue distribution, becaue it has a simple chemotaxis system with only three core chemoreceptors and it colonizes an organ with extreme chemical gradients. This proposal builds on our novel insights into the ligands and sensing mechanisms of H. pylori chemoreceptors. In this proposal, we will use structural, biophysical, and biochemical approaches to understand the precise mechanisms by which H. pylori chemoreceptors sense three key chemicals that define three important axes in the stomach environment: urea (secreted from the gastric epithelium, defining the epithelial to luminal axis), the bacterial-produced quorum sensing molecule autoinducer-2 (defining regions of high bacterial density in the gastric glands versus the overlying mucosa), and acid (produced by the parietal cells in the anterior corpus region, defining the corpus to antrum, as well as the epithelial to luminal axis in the corpus). We have engineered mutant H. pylori that are specifically defective in sensing one of these three chemicals and we have developed highly sensitive assays for quantifying H. pylori chemotactic responses. We will use these existing mutants, and others that we engineer based on our new insights into the chemosensing mechanisms, to understand how H. pylori cells organize themselves in response to chemical signals on cultured epithelial monolayers and during infection of the mouse stomach. Knowledge gained from these studies will lead to new strategies for preventing and treating H. pylori infections by altering the bacteria's distribution in the stomach. More generally, these studies will provide novel insights into how bacterial pathogens perceive and navigate the host environment, knowledge which will be crucial for designing the next generation of antibiotics that specifically target within-host properties of bacterial invaders.
描述(由申请人提供):幽门螺杆菌是一种人类胃部病原体,它寄生在世界上一半的人口中,并引起多种疾病,包括胃炎、溃疡和癌症。胃中细菌的分布与疾病结果相关,但决定这种分布的因素尚不清楚。我们假设趋化性,即细菌根据环境中的化学梯度感知和定向其运动的能力,是幽门螺杆菌在胃中分布的关键决定因素。幽门螺杆菌非常适合测试细菌趋化性在组织分布中的作用,因为它具有简单的趋化性系统,仅具有三个核心化学感受器,并且它在具有极端化学梯度的器官中定殖。该提议建立在我们对幽门螺杆菌化学感受器的配体和传感机制的新颖见解的基础上。在本提案中,我们将使用结构、生物物理和生化方法来了解幽门螺杆菌化学感受器感知三种关键化学物质的精确机制,这些化学物质定义了胃环境中的三个重要轴:尿素(从胃上皮分泌,定义了上皮细胞)到管腔轴)、细菌产生的群体感应分子自诱导剂-2(定义胃腺与上覆粘膜中细菌密度高的区域)和酸(由前体区域的壁细胞,定义体到窦,以及体中的上皮到管腔轴)。我们设计了突变型幽门螺杆菌,其在感知这三种化学物质之一方面存在特殊缺陷,并且我们开发了用于量化幽门螺杆菌趋化反应的高灵敏度测定法。我们将使用这些现有的突变体以及根据我们对化学传感机制的新见解设计的其他突变体,以了解幽门螺杆菌细胞如何组织自身以响应培养的上皮单层上的化学信号以及小鼠胃感染期间的化学信号。从这些研究中获得的知识将导致通过改变细菌在胃中的分布来预防和治疗幽门螺杆菌感染的新策略。更一般地说,这些研究将为细菌病原体如何感知和导航宿主环境提供新的见解,这些知识对于设计专门针对细菌入侵者的宿主内特性的下一代抗生素至关重要。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen J Guillemin其他文献
Karen J Guillemin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen J Guillemin', 18)}}的其他基金
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
- 批准号:
10227108 - 财政年份:2018
- 资助金额:
$ 31.75万 - 项目类别:
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
- 批准号:
10468041 - 财政年份:2018
- 资助金额:
$ 31.75万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
8997473 - 财政年份:2014
- 资助金额:
$ 31.75万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
8629573 - 财政年份:2014
- 资助金额:
$ 31.75万 - 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
- 批准号:
9118193 - 财政年份:2014
- 资助金额:
$ 31.75万 - 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
- 批准号:
8652710 - 财政年份:2014
- 资助金额:
$ 31.75万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
9207745 - 财政年份:2014
- 资助金额:
$ 31.75万 - 项目类别:
相似国自然基金
胰腺癌-肝脏双重类器官芯片的构建及其在胰腺癌肝转移机制研究中的应用
- 批准号:82302351
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
HJURP调控PRDX1增加雄激素受体蛋白稳定性导致前列腺癌细胞对恩扎卢胺耐药的机制
- 批准号:82373188
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
USP46通过去泛素化修饰RAP80促进同源重组修复的分子机制及其在三阴乳腺癌中的功能研究
- 批准号:82373150
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抑制MRPS21协同Bcl-xL抑制剂诱导前列腺癌细胞合成致死的分子机制研究
- 批准号:82303033
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
C17ORF49/BPTF/BORIS通过增强子重编程促进ERα阳性乳腺癌内分泌治疗耐药的功能及分子机制研究
- 批准号:82303138
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of drug conjugates of R-spondin peptibodies for the treatment of colorectal cancer
开发用于治疗结直肠癌的 R-spondin 肽体药物缀合物
- 批准号:
10696733 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Molecular engineering and systematic evaluation of bispecific aptamers to develop potent and efficacious therapies for the immunomodulation of Non-Small Cell Lung Cancer
双特异性适体的分子工程和系统评估,以开发有效的非小细胞肺癌免疫调节疗法
- 批准号:
10751309 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Ligand-Directed KRAS G12V Mutant-Specific Therapeutics
配体导向的 KRAS G12V 突变特异性治疗
- 批准号:
10757070 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Unmet needs for specific subsets of EGFR mutated lung cancer
EGFR 突变肺癌特定亚型的需求未得到满足
- 批准号:
10441928 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
ST6GalNAc-I/MUC5AC promoting angiogenesis in lung adenocarcinoma
ST6GalNAc-I/MUC5AC促进肺腺癌血管生成
- 批准号:
10513140 - 财政年份:2022
- 资助金额:
$ 31.75万 - 项目类别: